Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TWILIGHT: Ticagrelor Monotherapy vs DAPT After PCI
NCT02270242Phase 4Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Jul 2015
- Primary completion
- Jul 2019
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronary artery disease (CAD) comparing Aspirin + Ticagrelor with Placebo + Ticagrelor (2 arms). Primary endpoint: Bleeding Academic Research Consortium Type 2, 3, or 5 Bleeding at 12 months. Started Jul 2015; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02270242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02270242.